Contact this trialFirst, we need to learn more about you.
Glucagon Receptor Antagonist
Volagidemab for Low Blood Sugar in Type 1 Diabetes
Recruiting1 awardPhase 1
Walnut Creek, California
This trial will test how a new drug called volagidemab affects glucose recovery from low blood sugar in adults with type 1 diabetes. Participants will receive the drug once a week for 6
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.